Paper · 23202128
Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma.
Sausen M and 13 others. Nat Genet, 2013. Cited by 348 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma. Papers, record 23202128. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23202128
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| DNA-Binding Proteins | Major topic |
| Mutation | Major topic |
| Neuroblastoma | Major topic |
| Nuclear Proteins | Major topic |
| Transcription Factors | Major topic |
| Biomarkers, Tumor | |
| Cell Line, Tumor | |
| Child | |
| DNA Copy Number Variations | |
| Exome | |
| Gene Expression Profiling | |
| Gene Order | |
| Genomics | |
| Humans | |
| Sequence Analysis, DNA |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 CA121113 | NCI NIH HHS | United States | R01CA121113 | PubMed and NIH | NIH RePORTER |
| R37 CA043460 | NCI NIH HHS | United States | R37CA043460 | PubMed and NIH | NIH RePORTER |
| R37 CA057345 | NCI NIH HHS | United States | R37CA057345 | PubMed and NIH | NIH RePORTER |
| CA121113 | NCI NIH HHS | United States | R01CA121113 | PubMed and NIH | NIH RePORTER |
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References50
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 18,724,359 | Identification of ALK as a major familial neuroblastoma predisposition gene. | Nature | 2008 | https://conductscience.org/library/papers/18724359 | PubMed |
| 2 | 12,097,268 | Circulating MYCN DNA as a tumor-specific marker in neuroblastoma patients. | Cancer Res | 2002 | https://conductscience.org/library/papers/12097268 | PubMed |
| 3 | 20,981,092 | A map of human genome variation from population-scale sequencing. | Nature | 2010 | https://conductscience.org/library/papers/20981092 | PubMed |
| 4 | 21,798,897 | Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. | Science | 2011 | https://conductscience.org/library/papers/21798897 | PubMed |
| 5 | 16,959,974 | The consensus coding sequences of human breast and colorectal cancers. | Science | 2006 | https://conductscience.org/library/papers/16959974 | PubMed |
| 6 | 22,286,216 | Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas. | Nat Genet | 2012 | https://conductscience.org/library/papers/22286216 | PubMed |
| 7 | 22,722,829 | Novel mutations target distinct subgroups of medulloblastoma. | Nature | 2012 | https://conductscience.org/library/papers/22722829 | PubMed |
| 8 | 20,826,764 | Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma. | Science | 2010 | https://conductscience.org/library/papers/20826764 | PubMed |
| 9 | 22,286,061 | Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. | Nature | 2012 | https://conductscience.org/library/papers/22286061 | PubMed |
| 10 | 22,722,201 | The landscape of cancer genes and mutational processes in breast cancer. | Nature | 2012 | https://conductscience.org/library/papers/22722201 | PubMed |
1 to 10 of 50
See all 50 referencesCited by258
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 348 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,558,373 | Infantile giant intracranial-extracranial communicating mixed germ cell tumor with ARID1B gene mutation: a case report. | Front Oncol | 2026 | https://conductscience.org/library/papers/42558373 | PubMed |
| 42,524,535 | The Role of Precision Medicine in Neuroblastoma: Targeted Therapies and Personalized Approaches-A Narrative Review. | Health Sci Rep | 2026 | https://conductscience.org/library/papers/42524535 | PubMed |
| 42,272,085 | A Bayesian-Based Integrative Bioinformatics Analysis Nominates Oncogenic Drivers in Neuroblastoma. | Clin Transl Sci | 2026 | https://conductscience.org/library/papers/42272085 | PubMed |
| 42,010,939 | Next generation sequencing identifies novel gene alterations with potential prognostic relevance in pediatric cancer: a single-center study. | Oncologist | 2026 | https://conductscience.org/library/papers/42010939 | PubMed |
| 41,890,906 | Epigenetic crosstalk in neuroblastoma development and progression. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/41890906 | PubMed |
| 41,825,442 | The landscape of structural variation in pediatric cancer. | Cancer Cell | 2026 | https://conductscience.org/library/papers/41825442 | PubMed |
| 41,030,971 | The landscape of structural variation in pediatric cancer. | bioRxiv | 2025 | https://conductscience.org/library/papers/41030971 | PubMed |
| 41,001,036 | Significance of ARID1A in neuroblastoma onset mechanism. | Front Oncol | 2025 | https://conductscience.org/library/papers/41001036 | PubMed |
| 40,831,912 | Cell state plasticity in neuroblastoma. | EJC Paediatr Oncol | 2024 | https://conductscience.org/library/papers/40831912 | PubMed |
| 40,774,224 | High-dose DFMO alters protein translation in neuroblastoma. | Neoplasia | 2025 | https://conductscience.org/library/papers/40774224 | PubMed |
1 to 10 of 258
See all 258 cited byGenes35
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ALK | 238 | PubTator's text mining | https://conductscience.org/library/genes/238 | NCBI Gene |
| ANKRD34B | 340,120 | PubTator's text mining | https://conductscience.org/library/genes/340120 | NCBI Gene |
| APPBP2 | 10,513 | PubTator's text mining | https://conductscience.org/library/genes/10513 | NCBI Gene |
| ARID1A | 8,289 | PubTator's text mining | https://conductscience.org/library/genes/8289 | NCBI Gene |
| ARID1B | 57,492 | PubTator's text mining | https://conductscience.org/library/genes/57492 | NCBI Gene |
| ATRX | 546 | PubTator's text mining | https://conductscience.org/library/genes/546 | NCBI Gene |
| CREBBP | 1,387 | PubTator's text mining | https://conductscience.org/library/genes/1387 | NCBI Gene |
| DAXX | 1,616 | PubTator's text mining | https://conductscience.org/library/genes/1616 | NCBI Gene |
| EGFR | 1,956 | PubTator's text mining | https://conductscience.org/library/genes/1956 | NCBI Gene |
| EP300 | 2,033 | PubTator's text mining | https://conductscience.org/library/genes/2033 | NCBI Gene |
1 to 10 of 35
See all 35 genesDrugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data1
The data bank entries PubMed's record names. Trial numbers are under Trials.
| Data bank | Accession |
|---|---|
| GEO | GSE3960 |
Source GEO
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23202128
GET https://conductscience.org/api/papers/v1/23202128/references?page=2